03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Neupogen 30MU Syringe : | |
Type | Medicine Authorised |
Originator | Nivestim 30MU Syringes |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Amgen |
Responsible Party | Amgen Europe BV |
Origin | The Netherlands |
Manufacturer | Amgen Europe BV |
Origin | The Netherlands |
ATC | L03AA02 |
Revision Date | 01/01/2014 |
Neupogen 30MU Syringe :
Neupogen 30MU Syringe :
Neupogen 30MU Syringe :
Neupogen 30MU Syringe :
Neupogen 30MU Syringe :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Neupogen 30MU Syringe :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute febrile neutrophilic dermatosis (Sweet's syndrome) | Uncommon |
Acute respiratory distress syndrome | Uncommon |
Alopecia | Very Common |
Anaemia | Very Common |
Anaphylaxis | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
AST increased | Uncommon |
Asthenia | Very Common |
Back pain | Very Common |
Blood alkaline phosphatase increased | Very Common |
Blood glucose decreased | Very Common |
Blood lactate dehydrogenase increased | Very Common |
Blood uric acid increased | Very Common |
Bone density decreased | Common |
Bone pain | Very Common |
Capillary leak syndrome | Uncommon |
Chest pain | Common |
Constipation | Very Common |
Cough | Very Common |
Cutaneous vasculitis | Common |
Diarrhoea (Diarrhea) | Very Common |
Drug hypersensitivity | Common |
Dyspnoea (dyspnea) | Very Common |
Dysuria (Micturition painful) | Common |
Epistaxis (Nasal bleeding) | Very Common |
Fatigue | Very Common |
Fluid volume Disturbances | Uncommon |
Gamma-GT increased | Very Common |
Graft versus host disease | Uncommon |
Haematuria (Hematuria) | Common |
Haemoptysis | Common |
Headache | Very Common |
Hepatomegaly | Very Common |
Hypersensitivity | Not known |
Hyperuricaemia | Very Common |
Hypotension | Common |
Hypoxia | Uncommon |
Injection site reaction | Common |
Interstitial pneumonitis | Uncommon |
Leukaemia | Not known |
Leukocytosis | Very Common |
Lung infiltration (pulmonary infiltration) | Uncommon |
Mucosal inflammation | Very Common |
Musculoskeletal chest pain | Very Common |
Musculoskeletal pain | Very Common |
Myalgia | Very Common |
Myelodysplastic syndrome | Not known |
Nausea | Very Common |
Neck pain | Very Common |
Osteoporosis | Common |
Pain | Uncommon |
Pain in extremity (Pain in limb) | Very Common |
Pharyngolaryngeal pain | Very Common |
Proteinuria | Uncommon |
Pseudogout | Uncommon |
Pulmonary haemorrhage | Uncommon |
Pulmonary oedema | Uncommon |
Respiratory failure | Uncommon |
Rheumatoid arthritis aggravated | Uncommon |
Sickle cell crisis | Uncommon |
Skin rash | Very Common |
Splenic rupture | Common |
Splenomegaly (Spleen enlarged) | Very Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Urine abnormality | Uncommon |
Urticaria | Not known |
Venoocclusive disease | Uncommon |
Vomiting | Very Common |
Neupogen 30MU Syringe :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Neupogen 30MU Syringe MoH 7965 :
Form | Solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 1 x0.5ml |
Strength | 30MU |
Storage Condition | 2-8°C protect from light |
Public Price | 5250392.65 L.L. |
Stratum | B |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 4815/1 |
Submission date | 01/01/2014 |
Registration Year | 2015 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File